0000-0002-4637-2454 About
My name is Dr. Zafar Khan. I have completed my PhD and M.Pharm from Jamia Hamdard University in the Department of Pharmaceutics. My research area focuses on nanoformulation and microformulation, particularly on developing microbeads and nanoemulgels. These specialized areas of research are crucial in advancing drug delivery systems and enhancing therapeutic efficacy. Currently, I am working in the Research and Development department at AIMIL Pharmaceuticals. In this role, I am dedicated to innovating and improving pharmaceutical formulations that can contribute to better health outcomes. A passion for pharmaceutical sciences drives my work, and I am committed to exploring new frontiers in drug formulation to bring about meaningful advancements in the industry.
Employment
-
R&D Department, AIMIL Pharmaceuticles New Product Development (NPD)2024 - Present
Education
Education history is unavailable.
Projects & Funding
Projects & funding information is unavailable.
Publications (8)
- A Review on Novel Coronavirus (COVID-19) Vaccines: AstraZeneca, Pfizer, Moderna Save
- The Role of Artificial Intelligence in Diagnosing Malignant Tumors Save
- Development of Bedaquiline-Loaded SNEDDS Using Quality by Design (QbD) Approach to Improve Biopharmaceutical Attributes for the Management of Multidrug-Resistant Tuberculosis (MDR-TB) Save
- Co-delivery of exemestane and thymoquinone via nanostructured lipid carriers for efficient breast cancer therapy Save
- Recent advances in microbeads-based drug delivery system for achieving controlled drug release Save
- Superparamagnetic Iron-Oxide Nanoparticles Synthesized via Green Chemistry for the Potential Treatment of Breast Cancer Save
- Folic acid engineered sulforaphane loaded microbeads for targeting breast cancer Save
- Nanostructured Lipid Carrier-Based Codelivery of Raloxifene and Naringin: Formulation, Optimization, In Vitro, Ex Vivo, In Vivo Assessment, and Acute Toxicity Studies Save